DRUG compared with BIOA: revenue, margins and what each company keeps, and the suppliers and customers both name

DRUGBright Minds Biosciences Inc.

Mkt capRevenueRevenue

BIOABioAge Labs, Inc.

Mkt capRevenueRevenue

Compare

DRUGBright Minds Biosciences Inc.

BIOABioAge Labs, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DRUG 11

—Gerep Realtyunlistedsupplier

—Technology Innovation Centerunlistedsupplier

—ZoE Life Fulton Labs Incubatorunlistedsupplier

—Dr. Cunningham labunlistedsupplier

7 more · DRUG chain ›

Shared 0

No disclosed counterparties: BIOA.

Only BIOA 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

DRUGBright Minds Biosciences Inc.

27.26· pre 25.48· delayed

Mkt cap$200.1MRevenue—Revenue—

BIOABioAge Labs, Inc.

5.81· pre 5.60· delayed

Pre-marketNov 3 '26delayed

Mkt cap$260.1MRevenue$2MQ2 FY26Revenue$9MFY25

Compare

Pre-marketNov 3 '26delayed

DRUGBright Minds Biosciences Inc.

BIOABioAge Labs, Inc.

27.26pre 25.48delayed

Price

5.81pre 5.60delayed

$200.1M

Mkt cap

$260.1M

—

Revenue

$2MQ2 FY26

—

Revenue

$9MFY25

DRUG27.26vsBIOA5.81Pre-marketNov 3 '26delayed